University of Oklahoma — Oklahoma City, Oklahoma

Public research footprint of University of Oklahoma, compiled from the ClinicalTrials.gov public registry.

1,793

Registered studies

637

Active

276

Recruiting now

887

Completed

206

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Lung Non-Small Cell Carcinoma · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma

Recently updated registry entries

NCT03258554 — Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally… (Completed)
NCT05687110 — Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With… (Recruiting)
NCT06317649 — Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Oklahoma?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.